Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Summit Technology (BEAM) -- Ignore unavailable to you. Want to Upgrade?

To: John Liu who wrote (940)	7/2/1998 10:59:00 PM
From: Manny Gugliuzza	Read Replies (2) \| Respond to of 1386

AJS; I also have the same est.for Q2 due out on july 29th. .03e revised est from stocksmart= 01/02/98=.24 02/17/98=.16 06/30/98=.13 with earnings being revised down it will only make it easier to crush toward the end of the year as LCAV becomes profitable like LVCI FY 99=.25e not revised in a while. John i have not seen this market take anything that has happen to summit into account except the action by the FTC. FDA approval recently pop and drop; settlement with visx pop and drop also the price has held up well at 5.25 and until it is read in black and white as 35 million dollars on x amount of shares outstanding plus income from lenscrafters plus procedure income from LCAV. this is going to add up to one hell of a quarter. then maybe we will see "refections of the way things use to be". ar.